Resolution Therapeutics
Monday, February 26, 2024
Plymouth
Gene/Cell Therapy
Pioneering marcrophage cell therapy to transform the outcomes of patients with End Stage Liver Disease
Country
United Kingdom
Website
https://resolution-tx.com/
CEO/Top Company Official
Amir Hefni
Lead Product in Development
RTX001, autologous engineered macrophage cell therapy
Development Phase of Primary Product
Phase I
Number Of Unlicensed Products
2